Drug Shortage Report for JAMP-LOSARTAN HCTZ
Report ID | 95710 |
Drug Identification Number | 02408252 |
Brand name | JAMP-LOSARTAN HCTZ |
Common or Proper name | Losartan HCTZ |
Company Name | JAMP PHARMA CORPORATION |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
Strength(s) | 25MG 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2019-09-01 |
Estimated end date | 2022-12-30 |
Actual end date | 2022-09-06 |
Shortage status | Resolved |
Updated date | 2022-09-09 |
Company comments | This product have been discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2022-09-09 | French | Compare |
v11 | 2022-09-09 | English | Compare |
v10 | 2021-04-07 | French | Compare |
v9 | 2021-04-07 | English | Compare |
v8 | 2020-06-19 | French | Compare |
v7 | 2020-06-19 | English | Compare |
v6 | 2020-02-18 | French | Compare |
v5 | 2020-02-18 | English | Compare |
v4 | 2019-12-10 | French | Compare |
v3 | 2019-12-10 | English | Compare |
v2 | 2019-10-07 | French | Compare |
v1 | 2019-10-07 | English | Compare |
Showing 1 to 12 of 12